Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gastrolyte is an over-the-counter oral rehydration salts (ORS) product marketed by Novum Pharma, a Dutch international pharmaceutical company. It is formulated as a food supplement or consumer health product designed for the treatment and prevention of dehydration resulting from diarrhea. The product works by utilizing the sodium-glucose cotransport mechanism in the small intestine; the combination of glucose and sodium chloride (salt) facilitates the osmotic absorption of water, thereby naturally restoring fluid and electrolyte balance. Gastrolyte is available in several formulations, including flavored powders (Orange and Banana + Rice) and effervescent tablets, and is distributed in over 45-60 countries worldwide.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Gastrolyte.